BiotechTube
Home/Genelux/Thomas Zindrick
TZ

Thomas Zindrick

President, Chief Executive Officer and Chairman

Genelux

Therapeutic Areas

OncologyImmuno-Oncology

Genelux Pipeline

DrugIndicationPhase
Olvi-VecPlatinum-Resistant/Refractory Ovarian CancerPhase 3
V2ACT ImmunotherapyUndisclosed Solid TumorsPhase 1
V-VET1Canine CancersVeterinary

Leadership Team at Genelux

JL
James L. Tyree
Lead Independent Director
View full Genelux profile